Supplementary Table 2 from Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer

Autor: Jacek K. Pinski, Andrew V. Schally, Debra Hawes, Juergen Engel, Yu-Chong Tai, David I. Quinn, Tanya B. Dorff, Susan Groshen, Shigang Xiong, Denice D. Tsao-Wei, Stephen V. Liu
Rok vydání: 2023
DOI: 10.1158/1078-0432.22458390
Popis: Supplemental Table 2. Grade 1, 2, 3 and 4 adverse events including all cohorts (n=18). Toxicities defined as not related to treatment were excluded.
Databáze: OpenAIRE